• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PTX 5.08% 6.2¢

PRESCIENT THERAPEUTICS LIMITED

Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The... Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The Company is engaged in the development of personalized medicine approaches to cancer, including targeted and cellular therapies. Its product pipeline includes PTX-100, PTX-200, OmniCAR, CellPryme-M and CellPryme-A. PTX-100 is a compound with the ability to block a cancer growth enzyme, geranylgeranyl transferase-1 (GGT-1). PTX-100 is in Phase Ib expansion cohort study in T cell lymphomas. PTX-200 is a PH domain inhibitor that inhibits a tumor survival pathway, Akt. PTX-200 is in Phase Ib/II trial in relapsed and refractory AML. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single-cell product. CellPryme-M is a platform for enhancing cell therapies by producing cells with superior phenotypes. CellPryme-A is an adjuvant therapy designed to be administered to patients alongside cellular immunotherapy.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PTX
Daily happenings?.
6 7 8
16/04/24 469 198K
16/04/24 Last post  b1gcr4ig Comments Created with Sketch.  469  Views Created with Sketch.  198K 
PTX 16/04/24 11 4.9K
16/04/24 Last post  Shellbell Comments Created with Sketch.  11  Views Created with Sketch.  4.9K 
PTX
Live Investor Briefing - today
16/04/24 27 9.7K
16/04/24 Last post  dalts66 Comments Created with Sketch.  27  Views Created with Sketch.  9.7K 
PTX
PTX Media related
25 26 27
12/04/24 1.5K 626K
12/04/24 Last post  dalts66 Comments Created with Sketch.  1.5K  Views Created with Sketch.  626K 
PTX
updated chart
53 54 55
10/04/24 3.2K 1.1M
10/04/24 Last post  Mannydee Comments Created with Sketch.  3.2K  Views Created with Sketch.  1.1M 
PTX
Blocking agent
06/04/24 11 4.5K
06/04/24 Last post  Shellbell Comments Created with Sketch.  11  Views Created with Sketch.  4.5K 
PTX 05/04/24 0 434
05/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  434 
PTX
PTX - AI
07/03/24 1 1.0K
07/03/24 Last post  HotCrossBuns Comments Created with Sketch.  1  Views Created with Sketch.  1.0K 

See All Discussions arrow Created with Sketch.

Timeline

PTX100 Ph1b results to be presented at specialist congress
08 Apr 12:39
 
Notification of cessation of securities - PTX
05 Apr 12:55
 
Appendix 4D and Half Year Financial Report
23 Feb 10:14
 
December 2023 Quarterly Update and Appendix 4C
31 Jan 11:52
 
PTX-100 Spotlight Presentation
18 Dec 10:53
 
PTX-100 Ph1b results show excellent safety & efficacy in TCL
11 Dec 08:32
 
View More arrow Created with Sketch.
(20min delay)
Last
6.2¢
Change
0.003(5.08%)
Mkt cap ! $49.93M
Open High Low Value Volume
6.0¢ 6.2¢ 5.7¢ $57.08K 940.9K

Buyers (Bids)

No. Vol. Price($)
1 50000 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.2¢ 19407 1
View Market Depth
Last trade - 14.51pm 18/04/2024 (20 minute delay) ?
Last
6.2¢
  Change
0.003 ( 5.08 %)
Open High Low Volume
6.0¢ 6.2¢ 5.7¢ 429498
Last updated 14.27pm 18/04/2024 ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.